What about respiratory virus infections? Prevention for people living with diabetes in Covid times
Flu & Chronic Health Conditions Toolkit
The National Foundation for Infectious Diseases (NFID) has developed the following downloadable resources for Healthcare professionals (H...
RSV Disease in a COVID-19 era
Fourth webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Peter ...
COVID-19 Treatment and Medication
Third webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Marco G...
Childhood Influenza Vaccination and treatment in a COVID-19 era
Second webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and George...
Vaccination in a COVID-19 era
First webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Sylvie ...
Reports
Policy & Recommendations
News
|
8th influenza conference 2021
ESWI 2021 Conference Science Policy Interface highlights
A report summarising the Science Policy Interface Track
Video
Partner Organisations
|
7th Influenza Conference 2020
Should we introduce national live vaccination programmes for children?
ESPID/ESWI joint symposium supported by AZ
|
7th Influenza Conference 2020
Influenza in persons living with diabetes: Pathogenesis and prevention
Satellite Symposium by the IDC/supported by Sanofi Pasteur
Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection
The variable outcome of viral exposure is only partially explained by known factors. We administered respiratory syncytial virus (RSV) to 58 volunteers, of whom 57% became infected.
